nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CHRM3—Carbachol—glaucoma	0.107	0.111	CbGbCtD
Brompheniramine—CHRM3—Pilocarpine—glaucoma	0.0992	0.103	CbGbCtD
Brompheniramine—CHRM1—Carbachol—glaucoma	0.0928	0.0964	CbGbCtD
Brompheniramine—CHRM1—Pilocarpine—glaucoma	0.0863	0.0896	CbGbCtD
Brompheniramine—CHRM2—Carbachol—glaucoma	0.0856	0.0889	CbGbCtD
Brompheniramine—CHRM2—Pilocarpine—glaucoma	0.0796	0.0826	CbGbCtD
Brompheniramine—CYP2E1—Pilocarpine—glaucoma	0.0609	0.0632	CbGbCtD
Brompheniramine—CYP2E1—Methazolamide—glaucoma	0.0411	0.0427	CbGbCtD
Brompheniramine—CYP2D6—Carteolol—glaucoma	0.0383	0.0398	CbGbCtD
Brompheniramine—CYP2D6—Betaxolol—glaucoma	0.0258	0.0269	CbGbCtD
Brompheniramine—CYP2C19—Methazolamide—glaucoma	0.0258	0.0268	CbGbCtD
Brompheniramine—CYP2C9—Diclofenamide—glaucoma	0.0249	0.0259	CbGbCtD
Brompheniramine—CYP2C9—Dorzolamide—glaucoma	0.024	0.025	CbGbCtD
Brompheniramine—CYP2C19—Timolol—glaucoma	0.0219	0.0228	CbGbCtD
Brompheniramine—CYP2C9—Methazolamide—glaucoma	0.0214	0.0223	CbGbCtD
Brompheniramine—CYP2D6—Methazolamide—glaucoma	0.0196	0.0204	CbGbCtD
Brompheniramine—CYP3A4—Pilocarpine—glaucoma	0.0184	0.0192	CbGbCtD
Brompheniramine—CYP2D6—Timolol—glaucoma	0.0167	0.0173	CbGbCtD
Brompheniramine—CYP3A4—Brinzolamide—glaucoma	0.0145	0.015	CbGbCtD
Brompheniramine—CYP2D6—Clonidine—glaucoma	0.0142	0.0147	CbGbCtD
Brompheniramine—CYP3A4—Dorzolamide—glaucoma	0.014	0.0145	CbGbCtD
Brompheniramine—CYP3A4—Methazolamide—glaucoma	0.0125	0.0129	CbGbCtD
Brompheniramine—CYP3A4—Acetazolamide—glaucoma	0.00996	0.0103	CbGbCtD
Brompheniramine—CYP3A4—Clonidine—glaucoma	0.00901	0.00936	CbGbCtD
Brompheniramine—CYP2C8—Metabolism—CTSA—glaucoma	2.36e-05	0.00063	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—SMO—glaucoma	2.32e-05	0.000622	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—SMO—glaucoma	2.32e-05	0.00062	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—SMO—glaucoma	2.31e-05	0.000618	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—SMO—glaucoma	2.29e-05	0.000612	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—EDN1—glaucoma	2.26e-05	0.000606	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CA2—glaucoma	2.22e-05	0.000595	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—C3—glaucoma	2.18e-05	0.000583	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.17e-05	0.000582	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.17e-05	0.000582	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CA1—glaucoma	2.17e-05	0.000581	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—EDN1—glaucoma	2.17e-05	0.00058	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—TXN—glaucoma	2.15e-05	0.000576	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RPTOR—glaucoma	2.13e-05	0.00057	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RPTOR—glaucoma	2.12e-05	0.000568	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RPTOR—glaucoma	2.12e-05	0.000566	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CTSA—glaucoma	2.1e-05	0.000563	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RPTOR—glaucoma	2.1e-05	0.000561	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—C3—glaucoma	2.09e-05	0.000558	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NCK2—glaucoma	2.06e-05	0.000552	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NCK2—glaucoma	2.06e-05	0.00055	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NCK2—glaucoma	2.05e-05	0.000548	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NCK2—glaucoma	2.03e-05	0.000543	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SMO—glaucoma	2.03e-05	0.000543	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CA1—glaucoma	2e-05	0.000534	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CA2—glaucoma	1.99e-05	0.000531	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CA1—glaucoma	1.98e-05	0.00053	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—C3—glaucoma	1.98e-05	0.000529	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SMO—glaucoma	1.94e-05	0.00052	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.94e-05	0.000519	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.94e-05	0.000519	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CTSA—glaucoma	1.93e-05	0.000517	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CTSA—glaucoma	1.92e-05	0.000513	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—C3—glaucoma	1.89e-05	0.000507	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NTRK2—glaucoma	1.86e-05	0.000497	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—TXN—glaucoma	1.85e-05	0.000495	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—TP53—glaucoma	1.85e-05	0.000494	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CA2—glaucoma	1.83e-05	0.000489	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—TXN—glaucoma	1.81e-05	0.000485	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CA2—glaucoma	1.81e-05	0.000484	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NTRK2—glaucoma	1.78e-05	0.000475	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.77e-05	0.000473	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.77e-05	0.000473	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HDAC9—glaucoma	1.75e-05	0.000469	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HDAC9—glaucoma	1.75e-05	0.000468	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HDAC9—glaucoma	1.74e-05	0.000466	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HDAC9—glaucoma	1.73e-05	0.000462	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—EDN1—glaucoma	1.69e-05	0.000451	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—EDN1—glaucoma	1.68e-05	0.00045	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—EDN1—glaucoma	1.68e-05	0.000448	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GSTT1—glaucoma	1.67e-05	0.000446	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—EDN1—glaucoma	1.66e-05	0.000444	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NGFR—glaucoma	1.59e-05	0.000426	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—TXN—glaucoma	1.57e-05	0.000419	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EDN1—glaucoma	1.53e-05	0.00041	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.53e-05	0.000409	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NGFR—glaucoma	1.52e-05	0.000408	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EDN1—glaucoma	1.52e-05	0.000407	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NTRK1—glaucoma	1.51e-05	0.000405	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EDN1—glaucoma	1.51e-05	0.000403	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—C3—glaucoma	1.47e-05	0.000394	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—C3—glaucoma	1.47e-05	0.000393	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—C3—glaucoma	1.46e-05	0.000392	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—C3—glaucoma	1.45e-05	0.000388	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NTRK1—glaucoma	1.45e-05	0.000388	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GSTT1—glaucoma	1.44e-05	0.000384	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.43e-05	0.000383	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.42e-05	0.000379	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTT1—glaucoma	1.41e-05	0.000376	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—TXN—glaucoma	1.4e-05	0.000374	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CDKN2B—glaucoma	1.39e-05	0.000373	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SMO—glaucoma	1.37e-05	0.000367	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SMO—glaucoma	1.37e-05	0.000366	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SMO—glaucoma	1.36e-05	0.000365	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SMO—glaucoma	1.35e-05	0.000361	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—C3—glaucoma	1.34e-05	0.000358	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EDN1—glaucoma	1.34e-05	0.000358	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CDKN2B—glaucoma	1.33e-05	0.000357	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—C3—glaucoma	1.33e-05	0.000357	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—C3—glaucoma	1.33e-05	0.000356	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ABCA1—glaucoma	1.33e-05	0.000356	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CYP1B1—glaucoma	1.33e-05	0.000356	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—C3—glaucoma	1.32e-05	0.000352	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CA1—glaucoma	1.31e-05	0.000349	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TXN—glaucoma	1.29e-05	0.000344	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EDN1—glaucoma	1.28e-05	0.000343	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.28e-05	0.000342	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TXN—glaucoma	1.28e-05	0.000341	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.26e-05	0.000338	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CTSA—glaucoma	1.26e-05	0.000338	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NTRK2—glaucoma	1.26e-05	0.000336	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NTRK2—glaucoma	1.25e-05	0.000335	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NTRK2—glaucoma	1.25e-05	0.000334	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NTRK2—glaucoma	1.23e-05	0.00033	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NGF—glaucoma	1.23e-05	0.000329	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTT1—glaucoma	1.22e-05	0.000325	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CA2—glaucoma	1.19e-05	0.000319	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NGF—glaucoma	1.18e-05	0.000315	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—C3—glaucoma	1.17e-05	0.000313	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.16e-05	0.000311	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.15e-05	0.000309	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ABCA1—glaucoma	1.14e-05	0.000306	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CYP1B1—glaucoma	1.14e-05	0.000306	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CYP1B1—glaucoma	1.12e-05	0.0003	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ABCA1—glaucoma	1.12e-05	0.0003	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—C3—glaucoma	1.12e-05	0.000299	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—APOE—glaucoma	1.09e-05	0.000291	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTT1—glaucoma	1.08e-05	0.00029	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CAV1—glaucoma	1.08e-05	0.000288	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NGFR—glaucoma	1.08e-05	0.000288	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NGFR—glaucoma	1.07e-05	0.000287	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NGFR—glaucoma	1.07e-05	0.000286	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GSTM1—glaucoma	1.06e-05	0.000284	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NGFR—glaucoma	1.06e-05	0.000284	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—APOE—glaucoma	1.04e-05	0.000279	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CAV1—glaucoma	1.03e-05	0.000276	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—FN1—glaucoma	1.03e-05	0.000275	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NTRK1—glaucoma	1.02e-05	0.000274	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NTRK1—glaucoma	1.02e-05	0.000273	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NTRK1—glaucoma	1.02e-05	0.000272	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—BAD—glaucoma	1.01e-05	0.000271	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NTRK1—glaucoma	1.01e-05	0.000269	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTT1—glaucoma	9.98e-06	0.000267	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTT1—glaucoma	9.89e-06	0.000265	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—FN1—glaucoma	9.82e-06	0.000263	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.8e-06	0.000262	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—BAD—glaucoma	9.71e-06	0.00026	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP1B1—glaucoma	9.68e-06	0.000259	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ABCA1—glaucoma	9.68e-06	0.000259	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN2B—glaucoma	9.43e-06	0.000252	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN2B—glaucoma	9.4e-06	0.000252	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—MTHFR—glaucoma	9.39e-06	0.000251	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN2B—glaucoma	9.37e-06	0.000251	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN2B—glaucoma	9.28e-06	0.000248	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GSTM1—glaucoma	9.14e-06	0.000245	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EDN1—glaucoma	9.05e-06	0.000242	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EDN1—glaucoma	9.02e-06	0.000241	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EDN1—glaucoma	8.99e-06	0.000241	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTM1—glaucoma	8.95e-06	0.00024	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EDN1—glaucoma	8.9e-06	0.000238	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.75e-06	0.000234	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—APOE—glaucoma	8.74e-06	0.000234	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CAV1—glaucoma	8.66e-06	0.000232	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ABCA1—glaucoma	8.64e-06	0.000231	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP1B1—glaucoma	8.64e-06	0.000231	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TXN—glaucoma	8.41e-06	0.000225	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NGF—glaucoma	8.31e-06	0.000222	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NGF—glaucoma	8.29e-06	0.000222	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NGF—glaucoma	8.26e-06	0.000221	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NGF—glaucoma	8.18e-06	0.000219	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NOS3—glaucoma	8.15e-06	0.000218	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MTHFR—glaucoma	8.08e-06	0.000216	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.97e-06	0.000213	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ABCA1—glaucoma	7.95e-06	0.000213	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP1B1—glaucoma	7.95e-06	0.000213	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MTHFR—glaucoma	7.91e-06	0.000212	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—C3—glaucoma	7.9e-06	0.000212	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ABCA1—glaucoma	7.88e-06	0.000211	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP1B1—glaucoma	7.88e-06	0.000211	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—C3—glaucoma	7.88e-06	0.000211	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—C3—glaucoma	7.85e-06	0.00021	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NOS3—glaucoma	7.8e-06	0.000209	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—C3—glaucoma	7.78e-06	0.000208	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTM1—glaucoma	7.74e-06	0.000207	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—APOE—glaucoma	7.52e-06	0.000201	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CAV1—glaucoma	7.45e-06	0.000199	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—APOE—glaucoma	7.37e-06	0.000197	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—APOE—glaucoma	7.36e-06	0.000197	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—APOE—glaucoma	7.33e-06	0.000196	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—APOE—glaucoma	7.31e-06	0.000196	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CAV1—glaucoma	7.3e-06	0.000195	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CAV1—glaucoma	7.29e-06	0.000195	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CAV1—glaucoma	7.27e-06	0.000194	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CAV1—glaucoma	7.24e-06	0.000194	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—APOE—glaucoma	7.24e-06	0.000194	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CAV1—glaucoma	7.17e-06	0.000192	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CDKN1B—glaucoma	7.06e-06	0.000189	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FN1—glaucoma	6.94e-06	0.000186	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FN1—glaucoma	6.92e-06	0.000185	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTM1—glaucoma	6.91e-06	0.000185	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FN1—glaucoma	6.89e-06	0.000185	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—BAD—glaucoma	6.86e-06	0.000183	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MTHFR—glaucoma	6.84e-06	0.000183	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—BAD—glaucoma	6.83e-06	0.000183	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FN1—glaucoma	6.83e-06	0.000183	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—BAD—glaucoma	6.81e-06	0.000182	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CDKN1B—glaucoma	6.76e-06	0.000181	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—BAD—glaucoma	6.75e-06	0.000181	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—NOS3—glaucoma	6.55e-06	0.000175	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—glaucoma	6.54e-06	0.000175	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTT1—glaucoma	6.52e-06	0.000175	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—APOE—glaucoma	6.37e-06	0.00017	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTM1—glaucoma	6.35e-06	0.00017	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CAV1—glaucoma	6.31e-06	0.000169	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTM1—glaucoma	6.3e-06	0.000169	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—glaucoma	6.26e-06	0.000168	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MTHFR—glaucoma	6.11e-06	0.000163	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—glaucoma	5.99e-06	0.00016	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—glaucoma	5.87e-06	0.000157	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOE—glaucoma	5.68e-06	0.000152	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NOS3—glaucoma	5.64e-06	0.000151	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CAV1—glaucoma	5.63e-06	0.000151	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—glaucoma	5.62e-06	0.00015	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—glaucoma	5.62e-06	0.00015	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—glaucoma	5.57e-06	0.000149	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NOS3—glaucoma	5.52e-06	0.000148	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOS3—glaucoma	5.51e-06	0.000148	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOS3—glaucoma	5.49e-06	0.000147	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOS3—glaucoma	5.48e-06	0.000147	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOS3—glaucoma	5.42e-06	0.000145	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOE—glaucoma	5.23e-06	0.00014	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1B1—glaucoma	5.2e-06	0.000139	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ABCA1—glaucoma	5.2e-06	0.000139	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOE—glaucoma	5.18e-06	0.000139	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CAV1—glaucoma	5.18e-06	0.000139	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—glaucoma	5.15e-06	0.000138	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CAV1—glaucoma	5.14e-06	0.000137	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—glaucoma	5.05e-06	0.000135	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1B—glaucoma	4.78e-06	0.000128	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NOS3—glaucoma	4.77e-06	0.000128	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1B—glaucoma	4.76e-06	0.000127	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1B—glaucoma	4.74e-06	0.000127	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1B—glaucoma	4.7e-06	0.000126	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—glaucoma	4.44e-06	0.000119	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—glaucoma	4.42e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—glaucoma	4.41e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—glaucoma	4.39e-06	0.000118	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—glaucoma	4.36e-06	0.000117	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—glaucoma	4.35e-06	0.000116	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NOS3—glaucoma	4.26e-06	0.000114	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—glaucoma	4.25e-06	0.000114	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTM1—glaucoma	4.15e-06	0.000111	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—glaucoma	3.97e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—glaucoma	3.96e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—glaucoma	3.95e-06	0.000106	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NOS3—glaucoma	3.92e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—glaucoma	3.91e-06	0.000105	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—glaucoma	3.89e-06	0.000104	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NOS3—glaucoma	3.88e-06	0.000104	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—glaucoma	3.67e-06	9.83e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—glaucoma	3.58e-06	9.59e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—glaucoma	3.55e-06	9.5e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOE—glaucoma	3.42e-06	9.15e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CAV1—glaucoma	3.39e-06	9.06e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—glaucoma	3e-06	8.03e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—glaucoma	2.99e-06	8e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—glaucoma	2.98e-06	7.98e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—glaucoma	2.95e-06	7.9e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NOS3—glaucoma	2.56e-06	6.85e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—glaucoma	2.34e-06	6.27e-05	CbGpPWpGaD
